Jerry Todd Thompson

Title: Jerry Todd Thompson: Innovator in Immunotoxin Fusion Proteins

Introduction

Jerry Todd Thompson is a notable inventor based in Frenchville, PA (US). He has made significant contributions to the field of immunotoxin fusion proteins, holding a total of 5 patents. His work focuses on developing novel recombinant DT-based immunotoxins, which have important applications in medical science.

Latest Patents

One of Jerry Todd Thompson's latest patents is titled "Immunotoxin fusion proteins and means for expression thereof." This invention provides novel recombinant DT-based immunotoxins, specifically anti-T cell immunotoxin fusion proteins. The patent details immunotoxins that can be expressed in bacterial, yeast, or mammalian cells. Additionally, it outlines the means for expressing the immunotoxin fusion protein. The abstract emphasizes that it is provided to comply with the rules requiring a summary that allows readers to quickly ascertain the subject matter of the technical disclosure.

Career Highlights

Throughout his career, Jerry Todd Thompson has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Novartis AG. His experience in these institutions has contributed to his expertise in the field of immunotoxins.

Collaborations

Jerry has collaborated with notable colleagues such as David M Neville and Huaizhong Hu. These partnerships have likely enhanced his research and development efforts in immunotoxin technologies.

Conclusion

Jerry Todd Thompson is a distinguished inventor whose work in immunotoxin fusion proteins has the potential to impact medical treatments significantly. His contributions to the field are marked by his innovative patents and collaborations with esteemed organizations and colleagues.